Pattern of high-dose prednisolone-induced hyperglycaemia in COPD exacerbations

Journal of Pharmacy Practice and Research

Volumn 39, Issue 1, 2009, Pages 50-54

  Roberts, Gregory W ^a   Monteiro, Vinia E ^b  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ORAL ANTIDIABETIC AGENT; PREDNISOLONE;

AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ACTIVITY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG MEGADOSE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; OUTCOME ASSESSMENT; SEASONAL VARIATION; SIDE EFFECT; TREATMENT DURATION;

EID: 65549092316     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2009.tb00704.x     Document Type: Article

References (16)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.
2. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N EngI J Med 2006; 354: 449-61
3. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-15.
4. Krinsley JS. Effect of intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
5. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical site infection among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22: 607-12.
6. Kasiobrod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients hospitalized with and without recognized diabetes. Circulation 2005; 111: 3078-86.
7. Golden S, Peart-Vigilance C, Kao W, Brancati FL. Pre-operative glycemic control and risk of infectious complications in a cohort of adult with diabetes. Diabetes Care 1999; 22: 1408-14.
8. Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr 1998; 22: 77-81.
9. Capes SE, Hunt D, Mahnberg K, Pathak P, Gerstein HC. Stress hyperglycaemia and prognosis of stroke in diabetic and nondiabetic patients: a systematic overview. Stroke 2001; 32: 2426-32.
10. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003; 55: 33-8.
11. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Port and Diabetes Project. Endocr Pract 2004; 10 (suppl 2): 21-33.
12. Umpierrez GU, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycaemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82.
13. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61: 284-9.
14. Uzu. T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, et al. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal disease. Nephron Clin Pract 2007; 105: c54-c57.
15. Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Kojima M. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic disease. Pharmacotherapy 2004; 24: 508-14.
16. Gurwitz J, Bohn R, Glynn R, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycaemic therapy. Arch Int Med 1994; 154: 97-101.